SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-238688
Filing Date
2017-07-27
Accepted
2017-07-27 17:15:57
Documents
2
Period of Report
2017-07-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d431592d8k.htm 8-K 16320
2 EX-99.1 d431592dex991.htm EX-99.1 11748
  Complete submission text file 0001193125-17-238688.txt   29319
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13467 | Film No.: 17987080
SIC: 8731 Services-Commercial Physical & Biological Research